Michael Eaddy, PharmD, Ph.D., joined Xcenda in 2001 and, as a Vice President leads his team to help manufacturers generate evidence-based insights, as well as apply data analytics, to support their products' clinical or economic value propositions.
He specializes in advanced statistical techniques such as economic and retrospective analyses, assessing the control of unobserved heterogeneity with frailty models, and studying the effects of missing data on quality-of-life statistical decision. Michael’s clinical experience includes bone marrow transplants and soft-tissue cancer treatments, as well as analyzing outcomes research in cardiovascular, urological and mental health disorders. He’s led more than 50 adherence-based quality and outcomes assessments. He’s been published in the Journal of Managed Care Pharmacy and Journal of Clinical Psychopharmacology, among others and presented at the International Society for Pharmacoeconomics and Outcomes Research and Academy of Managed Care Pharmacy
Michael earned his BS in pharmacy, PharmD and Ph.D. in pharmaceutical and health outcomes sciences at the University of South Carolina.